These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. pHLIP-mediated translocation of membrane-impermeable molecules into cells. Thévenin D; An M; Engelman DM Chem Biol; 2009 Jul; 16(7):754-62. PubMed ID: 19635412 [TBL] [Abstract][Full Text] [Related]
23. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation. Kaplan AR; Pham H; Liu Y; Oyaghire S; Bahal R; Engelman DM; Glazer PM Mol Cancer Res; 2020 Jun; 18(6):873-882. PubMed ID: 32098827 [TBL] [Abstract][Full Text] [Related]
24. Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP. Reshetnyak YK; Yao L; Zheng S; Kuznetsov S; Engelman DM; Andreev OA Mol Imaging Biol; 2011 Dec; 13(6):1146-56. PubMed ID: 21181501 [TBL] [Abstract][Full Text] [Related]
25. Hybrid protein-peptide system for the selective pH-dependent binding and photodynamic ablation of cancer cells. Frolova AY; Pakhomov AA; Kakuev DL; Sungurova AS; Dremina AA; Mamontova ED; Deyev SM; Martynov VI J Photochem Photobiol B; 2023 Dec; 249():112803. PubMed ID: 37924677 [TBL] [Abstract][Full Text] [Related]
26. Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors. Zoonens M; Reshetnyak YK; Engelman DM Biophys J; 2008 Jul; 95(1):225-35. PubMed ID: 18359793 [TBL] [Abstract][Full Text] [Related]
27. Cellular delivery of doxorubicin mediated by disulfide reduction of a peptide-dendrimer bioconjugate. Burns KE; Delehanty JB Int J Pharm; 2018 Jul; 545(1-2):64-73. PubMed ID: 29709616 [TBL] [Abstract][Full Text] [Related]
28. Aggregation Behavior of pHLIP in Aqueous Solution at Low Concentrations: A Fluorescence Study. Rao BD; Chakraborty H; Keller S; Chattopadhyay A J Fluoresc; 2018 Jul; 28(4):967-973. PubMed ID: 29959578 [TBL] [Abstract][Full Text] [Related]
29. pHLIP peptide targets nanogold particles to tumors. Yao L; Daniels J; Moshnikova A; Kuznetsov S; Ahmed A; Engelman DM; Reshetnyak YK; Andreev OA Proc Natl Acad Sci U S A; 2013 Jan; 110(2):465-70. PubMed ID: 23267062 [TBL] [Abstract][Full Text] [Related]
30. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. An M; Wijesinghe D; Andreev OA; Reshetnyak YK; Engelman DM Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20246-50. PubMed ID: 21048084 [TBL] [Abstract][Full Text] [Related]
31. D-to-E and T19V Variants of the pH-Low Insertion Peptide and Their Doxorubicin Conjugates Interact with Membrane at Higher pH Ranges Than WT. Wachira FW; Githirwa DC; McPartlon T; Nazarenko V; Gonzales JJC; Gazura MM; Leen C; Clary HR; Alston C; Klees LM; Yao L; An M Biochemistry; 2023 Oct; 62(20):2997-3011. PubMed ID: 37793002 [TBL] [Abstract][Full Text] [Related]
32. Using Simulation to Understand the Role of Titration on the Stability of a Peptide-Lipid Bilayer Complex. Burns V; Mertz B Langmuir; 2020 Oct; 36(41):12272-12280. PubMed ID: 32988206 [TBL] [Abstract][Full Text] [Related]
33. Cooperative Nonbonded Forces Control Membrane Binding of the pH-Low Insertion Peptide pHLIP. Gupta C; Ren Y; Mertz B Biophys J; 2018 Dec; 115(12):2403-2412. PubMed ID: 30503536 [TBL] [Abstract][Full Text] [Related]
34. Roles of carboxyl groups in the transmembrane insertion of peptides. Barrera FN; Weerakkody D; Anderson M; Andreev OA; Reshetnyak YK; Engelman DM J Mol Biol; 2011 Oct; 413(2):359-71. PubMed ID: 21888917 [TBL] [Abstract][Full Text] [Related]
35. Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant. Vasquez-Montes V; Gerhart J; King KE; Thévenin D; Ladokhin AS Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):534-543. PubMed ID: 29138065 [TBL] [Abstract][Full Text] [Related]
36. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP). Andreev OA; Engelman DM; Reshetnyak YK Chim Oggi; 2009 Mar; 27(2):34-37. PubMed ID: 20037661 [TBL] [Abstract][Full Text] [Related]
37. pH-Dependent Transmembrane Activity of Peptide-Functionalized Gold Nanostars for Computed Tomography/Photoacoustic Imaging and Photothermal Therapy. Tian Y; Zhang Y; Teng Z; Tian W; Luo S; Kong X; Su X; Tang Y; Wang S; Lu G ACS Appl Mater Interfaces; 2017 Jan; 9(3):2114-2122. PubMed ID: 28058834 [TBL] [Abstract][Full Text] [Related]
38. Kinetics of pHLIP peptide insertion into and exit from a membrane. Slaybaugh G; Weerakkody D; Engelman DM; Andreev OA; Reshetnyak YK Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12095-12100. PubMed ID: 32409607 [TBL] [Abstract][Full Text] [Related]
39. Recent Advances in Imaging Agents Anchored with pH (Low) Insertion Peptides for Cancer Theranostics. Liu YC; Wang ZX; Pan JY; Wang LQ; Dai XY; Wu KF; Ye XW; Xu XL Molecules; 2023 Feb; 28(5):. PubMed ID: 36903419 [TBL] [Abstract][Full Text] [Related]
40. Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP). Segala J; Engelman DM; Reshetnyak YK; Andreev OA Int J Mol Sci; 2009 Aug; 10(8):3478-87. PubMed ID: 20111691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]